
Cantex Pharmaceuticals - Continued Development of Cancer Therapies and More Read more: bit.ly/3U4Z6ow #CantexPharmaceuticals

Health Professional Radio is an online 24 hour radio station for health professionals.

Cantex Pharmaceuticals - Continued Development of Cancer Therapies and More Read more: bit.ly/3U4Z6ow #CantexPharmaceuticals

New type of AI-Powered Data Fills Gaps Left By Clinical Trials Read more: bit.ly/3O6bOj6 #REALPEStudy #EKOS #Truveta

Immunocore - FDA Approved Treatment for Metastatic Uveal Melanoma Read more: bit.ly/3vNVNba #Immunocore

Spirovant Sciences - Potential of Gene Therapy in Targeting the Drivers of Cystic Fibrosis Read more: bit.ly/47PvSNW #SpirovantSciences

Lucid Diagnostics - EsoGuard ® Esophageal DNA Test Read more: bit.ly/3U1tDnj #EsoGuard

Ultra-Rare Inherited Form of High Cholesterol is Dangerously Underdiagnosed and Undertreated Read more: bit.ly/3U9b3cS #FamilyHeartFoundation

CIONIC - Bionic Clothing Medical Device for the Mobility Impaired Read more: bit.ly/3RlhFln #neurotech #multiplesclerosis #cerebralpalsy

Chronic Kidney Disease and the It Takes Two™ Initiative Read more: bit.ly/41ubOin #chronickidneydisease #kidneydisease #CKD

Can Artificial Intelligence be used to Diagnose Glaucoma? Read more: bit.ly/48c6Ysa #AAO2023 #AI #glaucoma

Rheumatoid Arthritis and the Potential of Exploring Combination Therapies Read more: bit.ly/3NtLjDT #ACR23 #Immunology #Rheumatology

European Society for Medical Oncology (ESMO) 2023 - Abstracts #2362MO and #2359O Read more: bit.ly/47YbE4W #ESMO2023

European Society for Medical Oncology (ESMO) 2023 - Presidential Symposium / Abstract #LBA5 Read more: bit.ly/485sChU #ESMO2023

European Society for Medical Oncology (ESMO) 2023 - Mini Oral/Abstract #LBA85 Read more: bit.ly/46SLeAu #ESMO2023

Spectral AI - Advancing AI-driven Burn Wound Imaging Technology Read more: bit.ly/3t7ikPg #SpectralAI #AI #WoundHealing

Voyce™ - On-Demand Medical Interpretation Read more: bit.ly/3RwBAPz #languageinterpreation #healthequity #healthcareenterprise

Global Phase 3 innovaTV301 Trial Results Read more: bit.ly/3R1jMLb #innovaTV301